Vaccine Development in the Time of COVID-19: The Relevance of the Risklick AI to Assist in Risk Assessment and Optimize Performance. - Quentin Haas; Nikolay Borisov; David Vicente Alvarez; Sohrab Ferdowsi; Leonhard von Mayenn; Douglas Teodoro; Poorya Amini (Frontiers Digit. Health, 2021)

Analysis of eligibility criteria clusters based on large language models for clinical trial design. - Alban Bornet; Philipp Khlebnikov; Florian Meer; Quentin Haas; Anthony Yazdani; Boya Zhang; Poorya Amini; Douglas Teodoro (J. Am. Medical Informatics Assoc., 2025)